ADAR1 Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-890	Closed	-$75K	–	288
2024 Q2	$75K	Sell	890 -25,910	-97%	-$2.18M	0.01%	170
2024 Q1	$1.96M	Buy	+26,800	New	+$1.96M	0.44%	40